This compound is primarily utilized in pharmaceutical research and development as a key intermediate in the synthesis of various biologically active molecules. Its structure, featuring a trifluoromethyl group and a piperazine ring, makes it valuable for designing compounds with potential therapeutic applications, particularly in central nervous system (CNS) disorders and infectious diseases. It is often employed in the preparation of small molecule inhibitors, receptor modulators, and other drug candidates due to its ability to enhance pharmacokinetic properties such as metabolic stability and bioavailability. Additionally, it serves as a building block in medicinal chemistry for constructing complex molecules with specific target interactions.